Claims for Patent: 6,933,146

Summary for Patent: 6,933,146

Title:	Methods and means for producing efficient silencing construct using recombinational cloning
Abstract:	Methods and vectors and kits are provided for producing chimeric nucleic acid constructs capable of producing dsRNA for silencing target nucleic acid sequences of interest using recombinational cloning.
Inventor(s):	Helliwell; Christopher A. (Canberra, AU), Wesley; Susan V. (Canberra, AU), Waterhouse; Peter M. (Canberra, AU)
Assignee:	Commonwealth Scientific and Industrial Research Corporation (Campbell, AU)
Application Number:	10/055,001
Patent Claims:	1. A vector comprising the following operably linked DNA fragments: an origin of replication allowing replication in a recipient cell (1), a selectable marker region (2) capable of being expressed in said recipient cell; and a chimeric DNA construct comprising in sequence: a promoter or promoter region (3) capable of being recognized by RNA polymerases of a eukaryotic cell; a first recombination site (4), a second recombination site (5), a third recombination site (6) and a fourth recombination site (7); a 3' transcription terminating and polyadenylation region (8) functional in said eukaryotic cell: wherein said first recombination site (4) and said fourth recombination site (7) are capable of reacting with a same recombination site; and said second recombination site (5) and said third recombination site (6), are capable of reacting with a same recombination site; and wherein said first recombination site (4) and said second recombination site (5) do not recombine with each other or with a same recombination site; or said third recombination site (6) and said fourth recombination site (7) do not recombine with each other or with a same recombination site. 2. The vector of claim 1, wherein said first (4) and second recombination site (5) flank a second selectable marker gene (10) and said third (6) and fourth recombination site (7) flank a third selectable marker gene (9). 3. The vector of claim 1, wherein said chimeric DNA construct comprises a region flanked by intron processing signals (11), functional in said eukaryotic cell, located between said second recombination site (5) and said third recombination site (6). 4. The vector of claim 3, wherein said region flanked by intron processing signals is an intron sequence functional in said eukaryotic cell. 5. The vector of claim 3, further comprising a fourth selectable marker gene (19), located between said second (5) and third recombination site (6). 6. The vector of claim 1, wherein said vector comprises a selectable marker gene selected from the group consisting of an, antibiotic resistance gene, a tRNA gene, an auxotrophic marker, a toxic gene, a phenotypic marker, an antisense oligonucleotide; a restriction endonuclease; a restriction endonuclease cleavage site, an enzyme cleavage site, a protein binding site, and a sequence complementary PCR primer. 7. The vector of claim 1, wherein said promoter (3) is a plant-expressible promoter. 8. The vector of claim 7, wherein said chimeric DNA construct is flanked by left and right border T-DNA sequences. 9. The vector of claim 8, further comprising a selectable marker gene capable of being expressed in plant cells located between said left and said right T-DNA border sequences. 10. The vector of claim 8, further comprising an origin of replication capable of functioning in Agrobacterium sp. 11. The vector of claim 1, wherein said first (4) and fourth recombination site (7) is attR1 comprising the nucleotide sequence of SEQ ID No 4 and said second (5) and third (6) recombination site is attR2 comprising the nucleotide sequence of SEQ ID No 5. 12. The vector of claim 1, wherein said first (4) and fourth recombination site (7) is attP1 comprising the nucleotide sequence of SEQ ID No 10 and said second (5) and third (6) recombination site is attP2 comprising the nucleotide sequence of SEQ ID No 11. 13. A vector comprising the sequence of SEQ ID No 13. 14. A vector comprising the sequence of SEQ ID No 23. 15. A vector comprising the sequence of SEQ ID No 24. 16. A vector comprising the sequence of SEQ ID No 25. 17. A vector comprising the sequence of SEQ ID No 26. 18. A kit comprising the vector of claim 1. 19. The kit of claim 18, further comprising at least one recombination protein capable of recombining a DNA segment comprising at least one of said recombination sites. 20. A vector according to claim 1, wherein the origin of replication allows replication in bacteria. 21. A vector according to claim 20, wherein the bacteria is Escherichia coli. 22. A vector according to claim 1, wherein said first recombination site (4) and said fourth recombination site (7) are identical. 23. A vector according to claim 1, wherein said second recombination site (5) and said third recombination site (6) are identical. 24. A method for making a chimeric DNA construct capable of expressing a dsRNA in a eukaryotic cell comprising the steps of combining in vitro: a vector according to claim 1; an insert DNA comprising a DNA segment of interest (12) flanked by a fifth recombination site (13) which is capable of recombining with said first (4) or fourth recombination site (7) on said vector; and a sixth recombination site (14) which is capable of recombining with said second (5) or third recombination site (6) on said vector; at least one site specific recombination protein capable of recombining said first (4) or fourth (7) and said fifth recombination site (13) and said second (5) or third (6) and said sixth recombination site (14); allowing recombination to occur so as to produce a reaction mixture comprising product DNA molecules, said product DNA molecules comprising in sequence: said promoter or promoter region (3) capable of being recognized by RNA polymerases of said eukaryotic cell; a recombination site (15) which is the recombination product of said first (4) and said fifth recombination site (13); said DNA fragment of interest (12); a recombination site (16) which is the recombination product of said second (4) and said sixth recombination site (14); a recombination site (17) which is the recombination product of said third (5) and said sixth recombination site (14); said DNA fragment of interest in opposite orientation (12); a recombination site (18) which is the recombination product of said fourth (7) and said fifth recombination site (13); and said 3' transcription terminating and polyadenylation region (8) functional in said eukaryotic cell; and selecting said product DNA molecules. 25. The method according to claim 24, wherein said insert DNA is a linear DNA molecule. 26. The method according to claim 24, wherein said insert DNA is a circular DNA molecule. 27. The method according to claim 24, wherein said at least one recombination protein is selected from (i) Int (.lambda. integrase) and IHF (integration host factor) and (ii) Int, Xis (.lambda. excisionase), and IHF. 28. The method according to claim 24, wherein multiple insert DNAs comprising different DNA fragments of interest are processed simultaneously.

Details for Patent 6,933,146

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2021-01-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2021-01-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2021-01-26